The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial.
 
Colette Ngozi Owens
No Relationships to Disclose
 
Augustine Iannotta
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
 
John F. Gerecitano
No Relationships to Disclose
 
Matthew J. Matasar
No Relationships to Disclose
 
Ariela Noy
Research Funding - Pharmacyclics
 
Craig H. Moskowitz
No Relationships to Disclose
 
Pamela Drullinsky
No Relationships to Disclose
 
Maria Lia Palomba
Consulting or Advisory Role - Pharmacyclics
 
David J. Straus
No Relationships to Disclose
 
Steven M. Horwitz
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium
Research Funding - Celgene; Infinity Pharmaceuticals; Kirin Pharmaceuticals; Millennium; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - ADC Therapeutics; Infinity Pharmaceuticals; Janssen; RAND Corporation
 
Andrew David Zelenetz
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Alissa Pharma; Amgen; Dr. Reddy's Laboratories; Genentech/Roche; Gilead Sciences; Hospira
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Kirin Pharmaceuticals
Other Relationship - Boehringer Ingelheim
 
Carol S. Portlock
No Relationships to Disclose
 
Anita Kumar
Stock and Other Ownership Interests - One Medical Oscar (I); Third Rock Ventures (I)
Research Funding - Pharmacyclics
 
Paul A. Hamlin
Honoraria - Genentech/Roche
Consulting or Advisory Role - Gilead Sciences; Pfizer
Research Funding - GlaxoSmithKline (Inst); Janssen (Inst); molecular templates (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)